The cytisine derivatives, CC4 and CC26, reduce nicotine-induced conditioned place preference in zebrafish by acting on heteromeric neuronal nicotinic acetylcholine receptors

Psychopharmacology

Volumn 231, Issue 24, 2014, Pages 4681-4693

  Ponzoni, Luisa ^a   Braida, Daniela ^a   Pucci, Luca ^b   Andrea, Donzelli ^a   Fasoli, Francesca ^a,b   Manfredi, Irene ^c   Papke, Roger L ^d   Stokes, Clare ^d   Cannazza, Giuseppe ^e   Clementi, Francesco ^a,b   Gotti, Cecilia ^a,b   Sala, Mariaelvina ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b CNR   (Italy)

^c IRCCS NEUROMED   (Italy)

^d UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Conditioned place preference; Cytisine derivatives; Dihydro beta erythroidine; Drug development; Methyllycaconitine; Nicotine; Nicotinic receptors subtypes; Oocyte expressed; Zebrafish; Conotoxin MII

Indexed keywords

1,2-BIS(CYTISIN-12-YL)ETHANE; 1,4-BIS(CYTISIN-12-YL)-2-BUTYNE; ALKALOID; BENZAZEPINE DERIVATIVE; NICOTINE; NICOTINIC AGENT; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; QUINOXALINE DERIVATIVE; VARENICLINE;

ANIMAL; DRUG EFFECTS; INSTRUMENTAL CONDITIONING; METABOLISM; ZEBRA FISH;

ALKALOIDS; ANIMALS; BENZAZEPINES; CONDITIONING, OPERANT; NICOTINE; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; QUINOXALINES; RECEPTORS, NICOTINIC; ZEBRAFISH;

EID: 84939896485     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-014-3619-x     Document Type: Article

References (54)

1. Ackerman KM, Nakkula R, Zirger JM, Beattie CE, Boyd RT (2009) Cloning and spatiotemporal expression of zebrafish neuronal nicotinic acetylcholine receptor alpha 6 and alpha 4 subunit RNAs. Dev Dyn Off Publ Am Assoc Anatomists 238:980-992
2. Alexander SP, Mathie A, Peters JA (2011) Guide to receptors and channels (GRAC), 5th edition. Br J Pharmacol 164(Suppl 1):S1-S324
3. Bencan Z, Levin ED (2008) The role of alpha7 and alpha4beta2 nicotinic receptors in the nicotine-induced anxiolytic effect in zebrafish. Physiol Behav 95:408-412
4. Biala G, Staniak N, Budzynska B (2010) Effects of varenicline and mecamylamine on the acquisition, expression, and reinstatement of nicotine-conditioned place preference by drug priming in rats. Naunyn Schmiedeberg's Arch Pharmacol 381:361-370
5. Braida D, Limonta V, Pegorini S, Zani A, Guerini-Rocco C, Gori E, Sala M (2007) Hallucinatory and rewarding effect of salvinorin A in zebrafish: kappa-opioid and CB1-cannabinoid receptor involvement. Psychopharmacology 190:441-448
6. Braida D, Ponzoni L, Martucci R, Sparatore F, Gotti C, Sala M (2014) Role of neuronal nicotinic acetylcholine receptors (nAChRs) on learning and memory in zebrafish. Psycopharmacol 231:1975-1985
7. Cahill K, Stead LF, Lancaster T (2011) NIC receptor partial agonists for smoking cessation. The Cochrane database of systematic reviews: CD006103
8. Carbonnelle E, Sparatore F, Canu-Boido C, Salvagno C, Baldani-Guerra B, Terstappen G, Zwart R, Vijverberg H, Clementi F, Gotti C (2003) Nitrogen substitution modifies the activity of cytisine on neuronal nicotinic receptor subtypes. Eur J Pharmacol 471:85-96
9. Eddins D, Petro A, Williams P, Cerutti DT, Levin ED (2009) NIC effects on learning in zebrafish: the role of dopaminergic systems. Psychopharmacology 202:103-109
10. Foulds J (2006) The neurobiological basis for partial agonist treatment of NIC dependence: varenicline. Int J Clin Pract 60:571-576
11. Freedman R (2007) Exacerbation of schizophrenia by varenicline. Am J Psychiatry 164:1269
12. George O, Lloyd A, Carroll FI, Damaj MI, Koob GF (2011) Varenicline blocks NIC intake in rats with extended access to NIC self-administration. Psychopharmacology 213:715-722
13. Gonzales D, Rennard SI, Nides M, Oncken C, Azoulay S, Billing CB, Watsky EJ, Gong J, Williams KE, Reeves KR (2006) Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. JAMA J Am Med Assoc 296:47-55
14. Gotti C, Clementi F, Fornari A, Gaimarri A, Guiducci S, Manfredi I, Moretti M, Pedrazzi P, Pucci L, Zoli M (2009) Structural and functional diversity of native brain neuronal nicotinic receptors. Biochem Pharmacol 78:703-711
15. Grabus SD, Martin BR, Brown SE, Damaj MI (2006) NIC place preference in the mouse: influences of prior handling, dose and strain and attenuation by nicotinic receptor antagonists. Psychopharmacology 184:456-463
16. Grady SR, Moretti M, Zoli M, Marks MJ, Zanardi A, Pucci L, Clementi F, Gotti C (2009) Rodent habenulo-interpeduncular pathway expresses a large variety of uncommon nAChR subtypes, but only the alpha3beta4 and alpha3beta3beta4 subtypes mediate acetylcholine release. J Neurosci Off J Soc Neurosci 29:2272-2282
17. Gupta T, Mullin MC (2010) Dissection of organs from the adult zebrafish. J Vis Exp 37:1717
18. Hughes JR, Stead LF, Lancaster T (2007) Antidepressants for smoking cessation. The Cochrane database of systematic reviews: CD000031
19. Jorenby DE, Hays JT, Rigotti NA, Azoulay S, Watsky EJ, Williams KE, Billing CB, Gong J, Reeves KR (2006) Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA J Am Med Assoc 296:56-63
20. Kedikian X, Faillace MP, Bernabeu R (2013) Behavioral and molecular analysis of nicotine-conditioned place preference in zebrafish. PLoS One 8:e69453
21. Kily LJ, Cowe YC, Hussain O, Patel S, McElwaine S, Cotter FE, Brennan CH (2008) Gene expression changes in a zebrafish model of drug dependency suggest conservation of neuro-adaptation pathways. J Exp Biol 211:1623-1634
22. Klee EW, Ebbert JO, Schneider H, Hurt RD, Ekker SC (2011) Zebrafish for the study of the biological effects of nicotine. NIC Tob Res Off J Soc Res NIC Tob 13:301-312
23. Levin ED, Limpuangthip J, Rachakonda T, Peterson M (2006) Timing of NIC effects on learning in zebrafish. Psychopharmacology 184:547-552
24. Levin ED, Bencan Z, Cerutti DT (2007) Anxiolytic effects of NIC in zebrafish. Physiol Behav 90:54-58
25. Marks MJ, Laverty DS, Whiteaker P, Salminen O, Grady SR, McIntosh JM, Collins AC (2010) John Daly's compound, epibatidine, facilitates identification of nicotinic receptor subtypes. J Mol Neurosci MN 40:96-104
26. Mathur P, Guo S (2010) Use of zebrafish as a model to understand mechanisms of addiction and complex neurobehavioral phenotypes. Neurobiol Dis 40:66-72
27. Matta SG, Balfour DJ, Benowitz NL, Boyd RT, Buccafusco JJ, Caggiula AR et al (2007) Guidelines on nicotine dose selection for in vivo research. Psychopharmacol (Berl) 190:269-319
28. Mihalak KB, Carroll FI, Luetje CW (2006) Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors. Mol Pharmacol 70:801-805
29. Moore TJ, Furberg CD, Glenmullen J, Maltsberger JT, Singh S (2011) Suicidal behavior and depression in smoking cessation treatments. PLoS One 6:e27016
30. Museo E, Wise RA (1994) Place preference conditioning with ventral tegmental injections of cytisine. Life Sci 55:1179-1186
31. Panula P, Chen YC, Priyadarshini M, Kudo H, Semenova S, Sundvik M, Sallinen V (2010) The comparative neuroanatomy and neurochemistry of zebrafish CNS systems of relevance to human neuropsychiatric diseases. Neurobiol Dis 40:46-57
32. Papke RL, Porter Papke JK (2002) Comparative pharmacology of rat and human alpha7 nAChR conducted with net charge analysis. Br J Pharmacol 137:49-61
33. Papke RL, Stokes C (2010) Working with OpusXpress: methods for high volume oocyte experiments. Methods 51:121-133
34. Papke RL, Ono F, Stokes C, Urban JM, Boyd RT (2012) The nicotinic acetylcholine receptors of zebrafish and an evaluation of pharmacological tools used for their study. Biochem Pharmacol 84:352-365
35. Petzold AM, Balciunas D, Sivasubbu S, Clark KJ, Bedell VM, Westcot SE, Myers SR, Moulder GL, Thomas MJ, Ekker SC (2009) NIC response genetics in the zebrafish. Proc Natl Acad Sci U S A 106:18662-18667
36. Picciotto MR, Kenny PJ (2013) Molecular mechanisms underlying behaviors related to NIC addiction. Cold Spring Harb Perspect Med 3:a012112
37. Pucci L, Grazioso G, Dallanoce C, Rizzi L, De Micheli C, Clementi F, Bertrand S, Bertrand D, Longhi R, De Amici M, Gotti C (2011) Engineering of alpha-conotoxin MII-derived peptides with increased selectivity for native alpha6beta2 nicotinic acetylcholine receptors. FASEB J Off Publ Fed Am Soc Exp Biol 25:3775-3789
38. Rasmussen T, Swedberg MD (1998) Reinforcing effects of nicotinic compounds: intravenous self-administration in drug-naive mice. Pharmacol Biochem Behav 60:567-573
39. Raupach T, van Schayck CP (2011) Pharmacotherapy for smoking cessation: current advances and research topics. CNS Drugs 25:371-382
40. Rink E, Wullimann MF (2002) Connections of the ventral telencephalon and tyrosine hydroxylase distribution in the zebrafish brain (Danio rerio) lead to identification of an ascending dopaminergic system in a teleost. Brain Res Bull 57:385-387
41. Rollema H, Chambers LK, Coe JW, Glowa J, Hurst RS, Lebel LA, Lu Y, Mansbach RS, Mather RJ, Rovetti CC, Sands SB, Schaeffer E, Schulz DW, Tingley FD 3rd, Williams KE (2007) Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid. Neuropharmacology 52:985-994
42. Rollema H, Wilson GG, Lee TC, Folgering JH, Flik G (2011) Effect of co-administration of varenicline and antidepressants on extracellular monoamine concentrations in rat prefrontal cortex. Neurochem Int 58:78-84
43. Sala M, Braida D, Pucci L, Manfredi I, Marks MJ, Wageman CR, Grady SR, Loi B, Fucile S, Fasoli F, Zoli M, Tasso B, Sparatore F, Clementi F, Gotti C (2013) CC4, a dimer of cytisine, is a selective partial agonist at alpha4beta2/alpha6beta2 nAChR with improved selectivity for tobacco smoking cessation. Br J Pharmacol 168:835-849
44. Singh S, Loke YK, Spangler JG, Furberg CD (2011) Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis. CMAJ Can Med Assoc J = J Assoc Med Can 183:1359-1366
45. Smith JW, Mogg A, Tafi E, Peacey E, Pullar IA, Szekeres P, Tricklebank M (2007) Ligands selective for alpha4beta2 but not alpha3beta4 or alpha7 nicotinic receptors generalise to the NIC discriminative stimulus in the rat. Psychopharmacology 190:157-170
46. Spiller K, Xi ZX, Li X, Ashby CR Jr, Callahan PM, Tehim A, Gardner EL (2009) Varenicline attenuates nicotine-enhanced brain-stimulation reward by activation of alpha4beta2 nicotinic receptors in rats. Neuropharmacology 57:60-66
47. Streisinger G (2000) The zebrafish book. Oregon Press, Eugene
48. Svoboda KR, Vijayaraghavan S, Tanguay RL (2002) Nicotinic receptors mediate changes in spinal motoneuron development and axonal pathfinding in embryonic zebrafish exposed to nicotine. J Neurosci Off J Soc Neurosci 22:10731-10741
49. Swain HA, Sigstad C, Scalzo FM (2004) Effects of dizocilpine (MK-801) on circling behavior, swimming activity, and place preference in zebrafish (Danio rerio). Neurotoxicol Teratol 26:725-729
50. Tonstad S, Tonnesen P, Hajek P, Williams KE, Billing CB, Reeves KR (2006) Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial. JAMA J Am Med Assoc 296:64-71
51. Vieira-Brock PL, Miller EI, Nielsen SM, Fleckenstein AE, Wilkins DG (2011) Simultaneous quantification of nicotine and metabolites in rat brain by liquid chromatography-tandem mass spectrometry. J Chromatogr B Anal Technol Biomed Life Sci 879:3465-3474
52. Walters CL, Brown S, Changeux JP, Martin B, Damaj MI (2006) The beta2 but not alpha7 subunit of the nicotinic acetylcholine receptor is required for nicotine-conditioned place preference in mice. Psychopharmacology 184:339-344
53. Zierler-Brown SL, Kyle JA (2007) Oral varenicline for smoking cessation. Ann Pharmacother 41:95-99
54. Zirger JM, Beattie CE, McKay DB, Boyd RT (2003) Cloning and expression of zebrafish neuronal nicotinic acetylcholine receptors. Gene Expr Patterns GEP 3:747-754